» Articles » PMID: 11323414

Functional Roles for the Cytoplasmic Domain of the Type III Transforming Growth Factor Beta Receptor in Regulating Transforming Growth Factor Beta Signaling

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2001 Apr 27
PMID 11323414
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Transforming growth factor beta (TGF-beta) signals through three high affinity cell surface receptors, TGF-beta type I, type II, and type III receptors. The type III receptor, also known as betaglycan, binds to the type II receptor and is thought to act solely by "presenting" the TGF-beta ligand to the type II receptor. The short cytoplasmic domain of the type III receptor is thought to have no role in TGF-beta signaling because deletion of this domain has no effect on association with the type II receptor, or with the presentation role of the type III receptor. Here we demonstrate that the cytoplasmic domains of the type III and type II receptors interact specifically in a manner dependent on the kinase activity of the type II receptor and the ability of the type II receptor to autophosphorylate. This interaction results in the phosphorylation of the cytoplasmic domain of the type III receptor by the type II receptor. The type III receptor with the cytoplasmic domain deleted is able to bind TGF-beta, to bind the type II receptor, and to enhance TGF-beta binding to the type II receptor but is unable to enhance TGF-beta2 signaling, determining that the cytoplasmic domain is essential for some functions of the type III receptor. The type III receptor functions by selectively binding the autophosphorylated type II receptor via its cytoplasmic domain, thus promoting the preferential formation of a complex between the autophosphorylated type II receptor and the type I receptor and then dissociating from this active signaling complex. These studies, for the first time, elucidate important functional roles of the cytoplasmic domain of the type III receptor and demonstrate that these roles are essential for regulating TGF-beta signaling.

Citing Articles

Network Analysis of Dysregulated Immune Response to COVID-19 mRNA Vaccination in Hemodialysis Patients.

Chang Y, Lee J, Huang K, Vagts C, Ascoli C, Edafetanure-Ibeh R Vaccines (Basel). 2024; 12(10).

PMID: 39460313 PMC: 11511558. DOI: 10.3390/vaccines12101146.


Protective Effects of Gnetin C from Melinjo Seed Extract against High-Fat Diet-Induced Hepatic Steatosis and Liver Fibrosis in NAFLD Mice Model.

Kabir T, Yoshiba H, Agista A, Sultana H, Ohsaki Y, Yeh C Nutrients. 2023; 15(18).

PMID: 37764672 PMC: 10538079. DOI: 10.3390/nu15183888.


Cervical immune activation during the luteal phase may compromise subsequent trans-cervical ram sperm transport†.

Abril-Parreno L, Krogenaes A, Druart X, Cormican P, Fair S, Meade K Biol Reprod. 2022; 107(4):967-976.

PMID: 35766421 PMC: 9562110. DOI: 10.1093/biolre/ioac130.


Exome Sequencing Identifies Genetic Variants Associated with Extreme Manifestations of the Cardiovascular Phenotype in Marfan Syndrome.

Jimenez Y, Paulsen C, Turner E, Iturra S, Cuevas O, Lay-Son G Genes (Basel). 2022; 13(6).

PMID: 35741789 PMC: 9223058. DOI: 10.3390/genes13061027.


Interleukin-1 and Transforming Growth Factor Beta: Commonly Opposing, but Sometimes Supporting, Master Regulators of the Corneal Wound Healing Response to Injury.

Wilson S Invest Ophthalmol Vis Sci. 2021; 62(4):8.

PMID: 33825855 PMC: 8039470. DOI: 10.1167/iovs.62.4.8.